Orgenesis Inc.·4

Jan 8, 5:37 PM ET

Miller Victor 4

4 · Orgenesis Inc. · Filed Jan 8, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
Miller Victor
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-02+200,000200,000 total
    Exercise: $0.50Exp: 2034-01-01Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]Equal vesting over the next eight quarters with the vesting of the first 25,000 options commencing on March 31, 2024, subject to the reporting person's continued service through the applicable vesting dates.

Documents

1 file
  • 4
    ownership.xmlPrimary